Accenture's estimated fair value is US$276 based on 2 Stage Free Cash Flow to Equity. With US$245 share price, Accenture ...
Results from an interim analysis in the Phase 2 STARBORN-1 trial of TARA-002 in pediatric LMs patients remain on track for 4Q ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback